about
GnRH agonist for triggering of final oocyte maturation: time for a change of practice?GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysisImpact of Mid-Luteal Phase GnRH Agonist Administration on Reproductive Outcomes in GnRH Agonist-Triggered Cycles: A Randomized Controlled TrialTreatment of Abnormal Vaginal Microbiota before Frozen Embryo Transfer: Case-Report and Minireview to Discuss the Longitudinal Treatment Efficacy of Oral Clindamycin.Pharmaceutical options for triggering of final oocyte maturation in ARTThe Luteal Phase after GnRHa Trigger-Understanding An Enigma86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children.GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology.The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.Aromatase inhibitors in stimulated IVF cycles.Azoospermia and ring chromosome 9--a case report.Paraurethral leiomyoma in a postmenopausal woman: first European caseHormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols.Endometrial Stromal Nodule: A Rarity and a Pathological Challenge.Efficacy and Safety of Pergoveris in Assisted Reproductive Technology--ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatmentLH-receptor gene expression in human granulosa and cumulus cells from antral and preovulatory follicles.Pregnancy and birth after intracytoplasmic sperm injection with normal testicular spermatozoa in a patient with azoospermia and tail stump epididymal spermAgonist depot versus OCP programming of frozen embryo transfer: a retrospective analysis of freeze-all cycles.Use of acupuncture in female infertility and a summary of recent acupuncture studies related to embryo transfer.A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technologyImproving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment.Biological versus chronological ovarian age: implications for assisted reproductive technology.Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study.Persistent Mullerian Duct Syndrome: a rare entity with a rare presentation in need of multidisciplinary management.GnRHa to trigger final oocyte maturation: a time to reconsider.The novel POSEIDON stratification of 'Low prognosis patients in Assisted Reproductive Technology' and its proposed marker of successful outcome.Preventing ovarian hyperstimulation syndrome: guidance for the clinician.Should Cochrane reviews be performed during the development of new concepts?The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.Elevated progesterone during ovarian stimulation for IVF.(Meta)analyze this: Systematic reviews might lose credibility.GnRH agonist triggering: recent developments.GnRHa trigger for final oocyte maturation: is HCG trigger history?Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches.Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.Ovarian hyperstimulation syndrome in the 21st century: the role of gonadotropin-releasing hormone agonist trigger and kisspeptin.The updated Cochrane review 2014 on GnRH agonist trigger: repeating the same errors.Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis.
P50
Q28308094-B1EA26C6-3D1D-458E-B9C4-92F637C9F43DQ33770533-8D77E651-5AFE-4AA8-A446-B1BAA81AC7BDQ33799681-90F22A29-80B5-4DA0-B78B-0A0F669EBA20Q33809638-D27B1747-67F6-4913-813F-E97F56A452DBQ34009789-0A468B9D-F17E-4546-BCCC-EEB79C951FF9Q34458877-AF5EC206-9CC8-4719-A943-E177B4B8AFE1Q34548143-8FD4F4AB-52EC-4045-8ADA-CADAD06B378DQ34636679-5106F797-DFE3-4AF5-AD14-2A9C63BA74D8Q34875744-37D39CB2-25A7-4BC5-B4A0-EAA03607EAA9Q34983821-8F3CB0F4-CEDE-476C-BA5D-FB62DADC30B7Q35147441-FAEEFACE-C00B-4E3D-B194-476ED1AFAFFBQ35160859-32A97A8C-2290-43B7-B815-43389E6D75D6Q35296260-44B10EE2-F460-42E1-BE09-03E015B61A69Q35822351-C8000A96-277C-4B83-9CE1-A87201010453Q35843213-9EE244BB-57EA-45F9-96B3-0DBA137DEC0CQ35844053-E71CC505-64CE-4DB1-8DFB-C5834FF6A7B7Q36134824-DE16254F-A203-42CF-8B65-182A4582E932Q36589271-503D1F6C-6C3E-4CFB-A55B-F45D134FC55EQ36594336-B245FACA-5DCC-45D9-9783-33B3CAA5E65FQ36723130-E416127A-B83F-4F91-813D-F8C9486EB3A7Q36959947-6E15ECBE-C9E9-43C5-ACD6-B0EC86342FC4Q37372180-F62FCE33-21E5-4115-9F71-95F40C8A210EQ37393945-4B64A5A8-C680-4D70-917A-0C0188B7BE71Q37425142-4564F56B-8088-4C3E-8209-E62B6EF7A0CFQ37427014-A612F4FB-BC7C-4AC2-8699-BAC2EC686E40Q37553591-52D70F63-8809-4C0A-97ED-D5266DC12868Q37635863-1A4F357F-2BED-4E32-8F52-1BEE723CFF7CQ37736733-C3358CFD-C9A3-4613-A6A9-628914CCF582Q37949281-5349ECF5-1F2C-4C7F-A922-FE6E0CD9E7EAQ37971192-145F930E-85B2-42FC-8D8E-58D3264AD044Q37989262-C06D32A4-3353-46DA-9D87-AC793B3EA0F6Q38041965-AB0AE690-4231-4359-AB76-8BE132F61F9FQ38075689-601C024E-79DD-4C8E-B946-C9D0B23BC686Q38231926-B7526AE4-7E14-499C-B0AA-C39AD9786F00Q38355567-1065A3A0-E83E-4AF2-8CE5-DB630823E7E8Q38381555-BC60AE75-FA90-46BF-AA63-30B6BA8B748AQ38391766-02BAD00C-FC87-432D-9A21-89F1F2BEDEEDQ38429206-A24CB031-60AA-403C-927D-C99808000BD6Q38495382-B6F2B970-5890-4287-B526-97D8E2C97E66Q38709165-B395D2EE-7ED3-4B68-B9F7-6A488E3D96B2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Peter Humaidan
@ast
Peter Humaidan
@en
Peter Humaidan
@es
Peter Humaidan
@nl
Peter Humaidan
@sl
type
label
Peter Humaidan
@ast
Peter Humaidan
@en
Peter Humaidan
@es
Peter Humaidan
@nl
Peter Humaidan
@sl
prefLabel
Peter Humaidan
@ast
Peter Humaidan
@en
Peter Humaidan
@es
Peter Humaidan
@nl
Peter Humaidan
@sl
P1153
P106
P1153
55974239100
57200607809
6603645756
P21
P214
73152682538023311327
P31
P496
0000-0001-6884-5366
P735
P7859
viaf-73152682538023311327